The Court of Appeal has ruled that the NHS in England has the power to fund a drug which prevents HIV infection in people at high risk of the virus. NHS England had previously said that local authorities should provide the pre-exposure prophylaxis drug - known as Prep - because they are responsible for preventative health. But the court insisted this fell within the remit … [Read more...]
Proud Study: Healthcare Worker Survey
Since 2012, the US Food and Drugs Administration have approved the use of daily Truvada (tenofovir co-formulated with emtricitabine) as pre-exposure prophylaxis (PrEP) for reducing the risk of sexual transmission of HIV infection. If PrEP were to be available as a biomedical intervention in the UK, healthcare providers would play a critical role in its … [Read more...]